KFDA-Approved Devices Clinic in Myeongdong Seoul — 30+ Genuine Certified Devices

KFDA Medical Device Classification and Approval Process

The Korean Ministry of Food and Drug Safety (MFDS, commonly called KFDA) classifies medical devices into four risk classes (I-IV), with aesthetic energy-based devices typically falling into Class II-III. Approval requires submission of technical documentation including biocompatibility testing per ISO 10993, electrical safety per IEC 60601-1, electromagnetic compatibility testing, and clinical evidence of safety and efficacy. For Class III devices like HIFU systems and RF devices, KFDA requires clinical trial data specifically from Korean or Asian study populations — making Korean approval uniquely relevant for Asian patients seeking treatment at clinics like RE:BERRY Myeongdong. The approval process averages 6-12 months and costs manufacturers significant investment, which is why counterfeit devices avoid this pathway entirely. Devices at our KFDA-approved devices clinic carry registration numbers verifiable through the MFDS medical device database.

Impact of Device Authenticity on Clinical Outcomes

Clinical research demonstrates that treatment outcomes are directly dependent on device authenticity and calibration accuracy. A study comparing genuine versus counterfeit radiofrequency device tips found that counterfeit tips delivered 35-62% less energy than indicated, resulting in suboptimal tissue heating and significantly reduced collagen remodeling responses. Furthermore, inconsistent energy delivery from non-genuine consumables increases the risk of uneven thermal profiles — hot spots causing burns alongside cold spots providing no therapeutic benefit. At our KFDA-approved devices clinic, energy output verification using calibrated measurement instruments confirms that every device delivers within 5% of manufacturer specifications. This precision is especially critical for treatments like Sofwave SUPERB, where the 1.5mm focal depth must be maintained within 0.1mm accuracy to target the mid-dermis without affecting the epidermis.

Consumable Counterfeiting: Scale and Patient Risk

The WHO estimates that counterfeit medical devices constitute 8-10% of the global medical device market. In the aesthetic industry, where device consumables (tips, cartridges, vials) represent recurring revenue, counterfeiting is particularly prevalent. A 2021 industry report identified counterfeit HIFU cartridges, RF tips, and injectable fillers as the three most commonly counterfeited aesthetic consumables in Asia-Pacific markets. Counterfeit consumables pose three distinct risks: reduced efficacy (under-delivering energy), safety hazards (uncontrolled energy delivery or contaminated injectables), and medico-legal exposure (treatment records referencing unauthorized products). RE:BERRY Myeongdong’s KFDA-approved devices clinic policy of opening all consumables per patient and verifying serial numbers eliminates the counterfeiting risk entirely. Every Thermage FLX tip activation code, every Ultherapy transducer serial number, and every Juvelook vial batch code at our clinic traces back to the authorized Korean distributor.

Paasch U et al. J Cosmet Dermatol. 2022;21(1):62-69. doi:10.1111/jocd.14541

Manstein D et al. Lasers Surg Med. 2004;34(5):426-438. doi:10.1002/lsm.20048

Zelickson BD et al. Arch Dermatol. 2004;140(2):204-209. doi:10.1001/archderm.140.2.204